Subscribe
Alert
Please keep in mind that merely contacting Nelson Mullins Riley & Scarborough LLP will not establish an attorney-client relationship. Nelson Mullins cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. Accordingly, please do not send Nelson Mullins any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and authorized in the form of an engagement letter from Nelson Mullins. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature. Clicking "Submit" acknowledges that you understand and agree with this notice.
Jeanne M. DiGiorgio
Of Counsel
One Financial Center
Suite 3500
Boston, MA 02111
Suite 3500
Boston, MA 02111
jeanne.digiorgio@nelsonmullins.com
Jeanne focuses her practice on intellectual property law in the biotechnology, chemistry, pharmaceutical, and life science fields.
Jeanne focuses her practice on intellectual property law in the biotechnology, chemistry, pharmaceutical, and life science fields.
Experience
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Experience in intellectual property prosecution, including complex patent portfolios, strategic landscape and freedom to operate reviews, and patentability and infringement opinions
- Knowledge in antibody therapeutics, genetic engineering, and vaccines
- Has represented counsel of leading biotechnology companies and responsible for assisting in the development of global IP strategy
Education
- Northeastern University School of Law, JD (1995)
- College of the Holy Cross, BA, Biology (1985)
Admissions
- Massachusetts
- U.S. District Court for the District of Massachusetts
- U.S. Patent & Trademark Office
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Experience in intellectual property prosecution, including complex patent portfolios, strategic landscape and freedom to operate reviews, and patentability and infringement opinions
- Knowledge in antibody therapeutics, genetic engineering, and vaccines
- Has represented counsel of leading biotechnology companies and responsible for assisting in the development of global IP strategy
Media
Professional Activities
- American Intellectual Property Law Association
- Boston Patent Law Association
- Association of University Technology Managers
Jeanne focuses her practice on intellectual property law in the biotechnology, chemistry, pharmaceutical, and life science fields.
Experience
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.- Experience in intellectual property prosecution, including complex patent portfolios, strategic landscape and freedom to operate reviews, and patentability and infringement opinions
- Knowledge in antibody therapeutics, genetic engineering, and vaccines
- Has represented counsel of leading biotechnology companies and responsible for assisting in the development of global IP strategy
Education
- Northeastern University School of Law, JD (1995)
- College of the Holy Cross, BA, Biology (1985)
Admissions
- Massachusetts
- U.S. District Court for the District of Massachusetts
- U.S. Patent & Trademark Office
Practice Areas
- American Intellectual Property Law Association
- Boston Patent Law Association
- Association of University Technology Managers
Highlights from the Firm’s Insights
“Prime Equity” and the NIL Era: Shedeur Sanders’ Contract Ushers...
September 3, 2025
From the Ballpark to the Courtroom: “Babe Ruth” Charged in...
August 26, 2025
FCC Download: Monthly Updates - September 2025
September 19, 2025
2026 Missing Middle Tax Exemption: Are You Ready?
September 17, 2025